Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

× No keyword cloud information.

77 in total

Review 1. Neovascularisation and its role in the osteoarthritic process.

Authors: R A Brown; J B Weiss
Journal: Ann Rheum Dis Date: 1988-11 Impact factor: 19.103

Review 2. Interleukin-1 and its biologically related cytokines.

Authors: C A Dinarello
Journal: Adv Immunol Date: 1989 Impact factor: 3.543

3. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.

Authors: E C Arner; M A Pratta
Journal: Arthritis Rheum Date: 1989-03

4. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

Authors: S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber
Journal: N Engl J Med Date: 1989-02-02 Impact factor: 91.245

5. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.

Authors: G R Dodge; A R Poole
Journal: J Clin Invest Date: 1989-02 Impact factor: 14.808

6. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors: B Henderson; E R Pettipher
Journal: Clin Exp Immunol Date: 1989-02 Impact factor: 4.330

7. The intracellular precursor of IL-1 beta is associated with microtubules in activated U937 cells.

Authors: C T Baldari; J L Telford
Journal: J Immunol Date: 1989-02-01 Impact factor: 5.422

8. Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit.

Authors: B Henderson; F M Rowe; C R Bird; A J Gearing
Journal: Clin Exp Immunol Date: 1988-12 Impact factor: 4.330

9. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors: G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal: Clin Exp Immunol Date: 1988-09 Impact factor: 4.330

10. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone.

Authors: R Schindler; C A Dinarello
Journal: J Immunol Methods Date: 1989-01-17 Impact factor: 2.303

16 in total

1. Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors: A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal: Ann Rheum Dis Date: 2000-06 Impact factor: 19.103

Review 2. The roles of catabolic factors in the development of osteoarthritis.

Authors: Dominick J Blasioli; David L Kaplan
Journal: Tissue Eng Part B Rev Date: 2013-12-11 Impact factor: 6.389

3. An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors: E Haker; E Theodorsson; T Lundeberg
Journal: Inflammation Date: 1997-02 Impact factor: 4.092

Review 4. The problem of choice: current biologic agents and future prospects in RA.

Authors: Ernest H Choy; Arthur F Kavanaugh; Simon A Jones
Journal: Nat Rev Rheumatol Date: 2013-02-19 Impact factor: 20.543

5. Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytes.

Authors: Akanit Itthiarbha; Thanyaluck Phitak; Saksri Sanyacharernkul; Peraphan Pothacharoen; Wilart Pompimon; Prachya Kongtawelert
Journal: In Vitro Cell Dev Biol Anim Date: 2011-12-18 Impact factor: 2.416

6. Calcitonin inhibits production of immunoglobulins, rheumatoid factor and interleukin-1 by mononuclear cells from patients with rheumatoid arthritis.

Authors: S Aida; M Okawa-Takatsuji; S Aotsuka; K Shimoji; R Yokohari
Journal: Ann Rheum Dis Date: 1994-04 Impact factor: 19.103

7. Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods.

Authors: V E Miller; K Rogers; K D Muirden
Journal: Rheumatol Int Date: 1993 Impact factor: 2.631

8. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis.

Authors: J Highton; B Carlisle; D G Palmer
Journal: Clin Exp Immunol Date: 1995-12 Impact factor: 4.330

9. Antiinflammatory effects of NADPH oxidase inhibitors.

Authors: R Miesel; D Sanocka; M Kurpisz; H Kröger
Journal: Inflammation Date: 1995-06 Impact factor: 4.092

Review 10. Benefit-risk assessment of diacerein in the treatment of osteoarthritis.

Authors: Elena Panova; Graeme Jones
Journal: Drug Saf Date: 2015-03 Impact factor: 5.606